U.S. Markets closed

Fate Therapeutics, Inc. (FATE)


NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
3.09-0.01 (-0.32%)
At close: 4:00PM EDT
People also watch
GNCACNATEVOKAKBADRNA
Currency in USD

Valuation Measures

Market Cap (intraday) 5127.93M
Enterprise Value 3N/A
Trailing P/E -3.06
Forward P/E 1-3.25
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)31.15
Price/Book (mrq)2.00
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Mar 31, 2017
Profitability
Profit Margin 0.00%
Operating Margin (ttm)-828.29%
Management Effectiveness
Return on Assets (ttm)-29.52%
Return on Equity (ttm)-74.45%
Income Statement
Revenue (ttm)4.11M
Revenue Per Share (ttm)0.12
Quarterly Revenue Growth (yoy)-22.30%
Gross Profit (ttm)4.4M
EBITDA -33.16M
Net Income Avi to Common (ttm)-35.21M
Diluted EPS (ttm)-1.01
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)82.3M
Total Cash Per Share (mrq)1.99
Total Debt (mrq)8.7M
Total Debt/Equity (mrq)13.62
Current Ratio (mrq)4.94
Book Value Per Share (mrq)1.54
Cash Flow Statement
Operating Cash Flow (ttm)-30.03M
Levered Free Cash Flow (ttm)-15.43M

Trading Information

Stock Price History
Beta 1.67
52-Week Change 384.52%
S&P500 52-Week Change 314.06%
52 Week High 35.68
52 Week Low 31.65
50-Day Moving Average 33.19
200-Day Moving Average 33.69
Share Statistics
Avg Vol (3 month) 3265.43k
Avg Vol (10 day) 3178.34k
Shares Outstanding 541.4M
Float 30.3M
% Held by Insiders 124.77%
% Held by Institutions 163.40%
Shares Short 3322.58k
Short Ratio 36.01
Short % of Float 31.18%
Shares Short (prior month) 32.19M
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A